XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Condensed Statements of (Loss) Income - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Product revenues $ 372,323 $ 260,715 $ 735,948 $ 528,372
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of sales $ 284,335 $ 201,338 $ 566,830 $ 404,882
Gross margin 87,988 59,377 169,118 123,490
Operating expenses:        
Net research and development expenses 24,696 19,325 49,841 39,759
Selling, general and administrative expenses 38,418 31,943 75,460 61,251
Impairment of goodwill 19,509   19,509  
Restructuring expenses 1,044 374 2,313 555
Total operating expenses 83,667 51,642 147,123 101,565
Operating income 4,321 7,735 21,995 21,925
Interest expense, net (1,932) (1,430) (6,076) (1,999)
Foreign currency gain (loss) 346 4,552 (1,723) 6,769
Other income 556 134 786 338
Earnings before income tax 3,291 10,991 14,982 27,033
Income tax expense 4,842 3,919 8,570 8,214
Net (loss) income $ (1,551) $ 7,072 $ 6,412 $ 18,819
Basic (loss) earnings per share $ (0.05) $ 0.21 $ 0.19 $ 0.57
Diluted (loss) earnings per share $ (0.05) $ 0.21 $ 0.19 $ 0.56
Weighted average number of shares – basic 33,018,939 33,119,085 33,099,817 33,077,029
Weighted average number of shares – diluted 33,018,939 33,426,123 33,327,977 33,421,987